Literature DB >> 8092887

Preoperative and postoperative CA-125 serum levels in primary fallopian tube carcinoma.

A C Rosen1, M Klein, H R Rosen, A H Graf, M Lahousen, A Reiner, N Vavra, L Auerbach.   

Abstract

Levels of CA-125 were determined pre- and postoperatively in 13 patients with fallopian tube cancer. Values before surgery were significantly higher (Median 1220 IU/ml, 90-5000 IU/ml) compared with postoperative levels (Median 194 IU/ml, 67-880 IU/ml) (P = 0.0052). Correlation analysis with FIGO stage and grading failed to show any statistical significance, but a trend for a positive correlation with FIGO stage and preoperative values could be observed. The CA-125 antigen is expressed by fallopian tube carcinoma and should therefore be used in diagnosis and follow-up.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8092887     DOI： 10.1007/bf02391799

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN： 0932-0067            Impact factor:   2.344


  16 in total

1.  Primary carcinoma of the fallopian tube.

Authors:  C Y HU; M L TAYMOR; A T HERTIG
Journal:  Am J Obstet Gynecol       Date:  1950-01       Impact factor: 8.661

2.  A CA125 score as a prognostic index in patients with ovarian cancer.

Authors:  A Rosen; P Sevelda; M Klein; J Spona; A Beck
Journal:  Arch Gynecol Obstet       Date:  1990       Impact factor: 2.344

3.  CA 125 serum levels correlated with second-look operations among ovarian cancer patients.

Authors:  J S Berek; R C Knapp; G D Malkasian; P T Lavin; C Whitney; J M Niloff; R C Bast
Journal:  Obstet Gynecol       Date:  1986-05       Impact factor: 7.661

4.  Clinical aspects of fallopian tube carcinoma.

Authors:  M G Dodson; J H Ford; H E Averette
Journal:  Obstet Gynecol       Date:  1970-12       Impact factor: 7.661

5.  [Primary carcinoma of the Fallopian tube--a clinical study of 37 cases (author's transl)].

Authors:  V Engeler; E Reinisch; W E Schreiner
Journal:  Geburtshilfe Frauenheilkd       Date:  1981-05       Impact factor: 2.915

6.  Levels of CA 125 in patients with recurrent carcinoma of the fallopian tube: two case histories.

Authors:  E Lootsma-Miklosova; J G Aalders; P H Willemse; H W de Bruijn
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1987-03       Impact factor: 2.435

7.  Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer.

Authors:  N Einhorn; R C Bast; R C Knapp; B Tjernberg; V R Zurawski
Journal:  Obstet Gynecol       Date:  1986-03       Impact factor: 7.661

8.  Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas.

Authors:  T L Klug; R C Bast; J M Niloff; R C Knapp; V R Zurawski
Journal:  Cancer Res       Date:  1984-03       Impact factor: 12.701

9.  A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.

Authors:  R C Bast; T L Klug; E St John; E Jenison; J M Niloff; H Lazarus; R S Berkowitz; T Leavitt; C T Griffiths; L Parker; V R Zurawski; R C Knapp
Journal:  N Engl J Med       Date:  1983-10-13       Impact factor: 91.245

10.  Primary carcinoma of the fallopian tube--a retrospective analysis of 115 patients. Austrian Cooperative Study Group for Fallopian Tube Carcinoma.

Authors:  A Rosen; M Klein; M Lahousen; A H Graf; A Rainer; N Vavra
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640
View more
  1 in total

Review 1.  Primary fallopian tube cancer: a review of the literature.

Authors:  A C Hellström
Journal:  Med Oncol       Date:  1998-04       Impact factor: 3.064
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.